BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization ...

given pharmaceutical companies can either ask a national regulator or the European Medicines Agency (EMA) to greenlight their drug. Once that happens, national and regional authorities decide on ...

Capricor Therapeutics (CAPT) stock in focus as company receives Orphan Drug and ATMP designations from the EU regulator for its lead drug deramiocel. Read more here.

Milestone represents a significant step forward in the development of deramiocel for the treatment of Duchenne muscular ...

Ocugen, Inc. (OCGN) announced the European Medicines Agency has granted orphan medicinal product designation for OCU410ST for the ...

Clinuvel Pharmaceuticals (ASX:CUV) has entered discussions with the European Medicines Agency to increase the recommended ...

Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.Don't Miss out on Research Tools:Discover the latest stocks recommended by top ...

Following a turbulent period marked by Brexit and the pandemic, Ben Hargreaves finds the agency aiming to streamline ...

The upcoming Clinical Trials Supply and Outsourcing in Clinical Trials East Asia conferences will host discussions on supply ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

It also has a marketing application to the European Medicines Agency, with a decision expected in 2025. BridgeBio has granted ...

The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.